Suraj Kapa is a cardiac electrophysiologist at Mayo Clinic. He started on faculty at Mayo in 2013 after completing his internal medicine training at Mayo Clinic in Rochester, MN and cardiology and electrophysiology fellowships at the University of Pennsylvania. Over the course of his career he has published over 200 peer-reviewed articles and book chapters and given over 100 invited lectures nationally and internationally. He has been highly sought after for his views on the future of digital health, having spoken at CES, Webit, Exponential Medicine and for venture groups on behalf of Frost & Sullivan, at the Harvard Club, and in other venues. Over the course of his tenure at Mayo he has filed over 30 patents resulting in start-up companies related to non-invasive carbon beam ablation and licensing deals related to artificial intelligence algorithms. In addition, he has been invited to serve as a strategic advisor both for his clinical expertise with companies such as Boston Scientific and Abbott as well as his digital and business expertise with companies such as Myant (a wearable sensor company), BioSig (a signal processing company for whom he helped develop the data science infrastructure), and TripleBlind (a data encryption company focused on financial AI algorithms). Academically, Dr. Kapa’s areas of expertise relate to complex ablation, particularly for ventricular tachycardia, and he has been considered one of the world’s leading experts in new technology in this arena, having developed novel algorithms that have recently achieved regulatory approval. He is a well-recognized expert in cardiology, serving on journal editorial boards and also as a vice-chair, author, or reviewer on several scientific consensus statements. In addition, his work on digital tools to address the COVID-19 pandemic has been featured in the Wall Street Journal, Stat, and on CNBC. Currently, he also serves as the lead for innovation related to virtual (VR) and augmented (AR) reality. In that capacity, he has led collaborative engagement with several companies, academic centers, and is helping lead development of new technologies. During the nearly 2 years he has served in this capacity, he has developed a VR innovation space at Mayo Clinic, led the development of an enterprise-wide working consortium to leverage shared interests and draft a white paper, and started several research protocols. In parallel, he has begun collaborations with MIT and UIUC to work on developing new IP related to AR and VR technologies in additional to models for utilization of these devices to expand patient and provider reach. He is looking forward to sharing the opportunities in using AR and VR to advance medicine and scale Mayo expertise globally.